Nathan Rich
Stock Analyst at Goldman Sachs
(1.07)
# 3,463
Out of 4,829 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $16.77 | +25.22% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $162.47 | +20.64% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $16.69 | +79.80% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $7.60 | +5.26% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $18.53 | -5.53% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $250.49 | +53.70% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $12.85 | +8.95% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $17.83 | -38.31% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $188.51 | +19.36% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $508.47 | +27.83% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $63.63 | +38.30% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $14.81 | -18.97% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $70.08 | +21.29% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $8.96 | +22.84% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $324.70 | +3.17% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $379.22 | +41.08% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $16.77
Upside: +25.22%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $162.47
Upside: +20.64%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $16.69
Upside: +79.80%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $7.60
Upside: +5.26%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $18.53
Upside: -5.53%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $250.49
Upside: +53.70%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $12.85
Upside: +8.95%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $17.83
Upside: -38.31%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $188.51
Upside: +19.36%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $508.47
Upside: +27.83%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $63.63
Upside: +38.30%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $14.81
Upside: -18.97%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $70.08
Upside: +21.29%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $8.96
Upside: +22.84%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $324.70
Upside: +3.17%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $379.22
Upside: +41.08%